Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; Entamoeba histolytica group
CPT4 code
Name of the Procedure:
Infectious Agent Antigen Detection by Immunoassay Technique (e.g., Enzyme Immunoassay [EIA], Enzyme-Linked Immunosorbent Assay [ELISA], Immunochemiluminometric Assay [IMCA]) – Qualitative or Semiquantitative, Multiple-Step Method; Entamoeba histolytica Group
Summary
This procedure detects antigens of the Entamoeba histolytica group in a sample, helping to diagnose infections caused by this parasite. The process employs immunoassay techniques such as EIA, ELISA, or IMCA to identify the presence of the pathogen.
Purpose
The primary aim is to diagnose infections caused by Entamoeba histolytica, which can result in conditions like amoebic dysentery or liver abscess. Early and accurate detection helps in effective treatment and management of the infection.
Indications
- Persistent diarrhea
- Abdominal pain
- Blood or mucus in stool
- Fever
- History of travel to or residence in endemic areas
- Signs of liver involvement, such as liver abscess
Preparation
- No fasting required.
- Collect stool samples as per the healthcare provider's instructions.
- Inform the doctor about any medications or supplements being taken.
Procedure Description
- Sample Collection: A stool sample is collected from the patient.
- Antigen Extraction: Antigens from Entamoeba histolytica are extracted from the sample.
- Immunoassay Process: Using tools such as EIA, ELISA, or IMCA, the sample undergoes multiple steps to detect the presence of Entamoeba histolytica antigens.
- EIA/ELISA: Antibodies attached to enzymes detect and bind to the antigens.
- IMCA: Antibodies tagged with light-emitting markers detect and bind to antigens.
- Detection: The presence of antigens is identified through color change or luminescence, indicating a positive or negative result.
Tools and Equipment:
- Test kits
- Microplates coated with antibodies
- Substrates for enzyme reactions or chemiluminescence
- Reader devices for detecting color change or luminescence
Duration
The testing process typically takes a few hours to complete, though result availability may vary.
Setting
The procedure is usually carried out in a laboratory setting.
Personnel
- Clinical laboratory scientists or technologists
- Pathologists (for result interpretation and consultation)
Risks and Complications
- Minimal risks in terms of sample collection.
- False positives or negatives are possible, necessitating further testing.
Benefits
- Accurate and timely diagnosis of Entamoeba histolytica infections.
- Prompt initiation of appropriate treatment, leading to better health outcomes.
- Results can typically be obtained within a day.
Recovery
- No recovery needed as this is a non-invasive test.
- Follow-up appointments only if treatment is required based on the results.
Alternatives
- Microscopic examination of stool samples.
- Polymerase Chain Reaction (PCR) tests for genetic material of the pathogen.
Pros and Cons:
- Microscopic Examination: Less expensive but less sensitive.
- PCR: More sensitive and specific, but more costly.
Patient Experience
- The patient will need to collect stool samples, which may be uncomfortable.
- Generally, no pain or discomfort during the procedure itself.
- The patient may need to wait for results before knowing the next steps in their treatment plan.
Pain Management and Comfort Measures:
- No pain management required for this non-invasive test.